Cordium Pharmaceuticals Pvt Ltd, a leading global pharma exporter in India, offers premium-quality Trastuzumab Biosimilar Injection (150mg & 440mg) for the effective treatment of HER2-positive cancers. With fast and secure worldwide delivery, we supply to major international markets including UAE, USA, UK, and South Africa.
š¬ What is Trastuzumab Biosimilar?
Trastuzumab is a monoclonal antibody that specifically targets the HER2 receptor, overexpressed in certain breast and gastric cancers. This biosimilar provides equivalent efficacy and safety compared to the original biologic, at a more affordable cost.
š Indications / Uses
HER2-positive breast cancer (early-stage & metastatic)
HER2-positive gastric (stomach) cancer
Used alone or in combination with chemotherapy
š Dosage & Administration
Administered via intravenous (IV) infusion under medical supervision
Standard dosing:
Loading dose: 8 mg/kg
Maintenance dose: 6 mg/kg every 3 weeks
Dosage may vary based on patient condition and physician recommendation
ā ļø Side Effects
Common side effects may include:
Fever & chills
Nausea and vomiting
Fatigue
Diarrhea
Infusion-related reactions
Serious (rare) side effects:
Cardiotoxicity (heart-related issues)
Lung complications
Severe allergic reactions
šØ Precautions
Regular cardiac monitoring is essential
Not recommended during pregnancy or breastfeeding
Inform your doctor about existing heart conditions
Administer only under qualified healthcare supervision
š Global Export & Fast Shipping
Cordium Pharmaceuticals ensures reliable international supply with express delivery to:
UAE: Dubai, Abu Dhabi, Sharjah
USA: New York City, Los Angeles, Washington
UK: London, Manchester, Birmingham
South Africa: Johannesburg, Cape Town, Durban
ā Why Choose Cordium Pharmaceuticals?
Trusted Indian pharma exporter
Competitive pricing on oncology medicines
Strict quality assurance & compliance
Fast worldwide logistics support
š Contact Us Today for Bulk Orders & Enquiries:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
š¬ What is Trastuzumab Biosimilar?
Trastuzumab is a monoclonal antibody that specifically targets the HER2 receptor, overexpressed in certain breast and gastric cancers. This biosimilar provides equivalent efficacy and safety compared to the original biologic, at a more affordable cost.
š Indications / Uses
HER2-positive breast cancer (early-stage & metastatic)
HER2-positive gastric (stomach) cancer
Used alone or in combination with chemotherapy
š Dosage & Administration
Administered via intravenous (IV) infusion under medical supervision
Standard dosing:
Loading dose: 8 mg/kg
Maintenance dose: 6 mg/kg every 3 weeks
Dosage may vary based on patient condition and physician recommendation
ā ļø Side Effects
Common side effects may include:
Fever & chills
Nausea and vomiting
Fatigue
Diarrhea
Infusion-related reactions
Serious (rare) side effects:
Cardiotoxicity (heart-related issues)
Lung complications
Severe allergic reactions
šØ Precautions
Regular cardiac monitoring is essential
Not recommended during pregnancy or breastfeeding
Inform your doctor about existing heart conditions
Administer only under qualified healthcare supervision
š Global Export & Fast Shipping
Cordium Pharmaceuticals ensures reliable international supply with express delivery to:
UAE: Dubai, Abu Dhabi, Sharjah
USA: New York City, Los Angeles, Washington
UK: London, Manchester, Birmingham
South Africa: Johannesburg, Cape Town, Durban
ā Why Choose Cordium Pharmaceuticals?
Trusted Indian pharma exporter
Competitive pricing on oncology medicines
Strict quality assurance & compliance
Fast worldwide logistics support
š Contact Us Today for Bulk Orders & Enquiries:
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Keywords
